Pre-Expanded Fronto-Scalp Flaps Combined With Botulinum Toxin and Laser Therapy for Secondary Large-Scale Craniofacial Defects.

Journal of cosmetic dermatology 2026 Vol.25(1) p. e70624

Chu F, Liu S, Tang Y, Geng J

관련 도메인

Abstract

[BACKGROUND] Secondary facial defects remain a primary focus in plastic surgery, particularly large defects involving the midface, forehead, and scalp. While tissue expansion of the fronto-scalp flap offers a viable reconstructive option, the lengthy expansion period and the issue of post-expansion flap retraction necessitate further solutions.

[OBJECTIVE] We conducted a prospective, comparative clinical study to investigate the role of Botulinum toxin in the expansion of fronto-scalp flaps.

[METHOD] Between December 2019 and December 2024, 40 patients with large upper facial or scalp lesions were enrolled and randomly assigned to either the experimental group or the control group. Control group patients underwent tissue expansion combined with postoperative laser hair removal. Experimental group patients received the same tissue expansion and laser therapy, supplemented with Botulinum toxin injections administered both preoperatively (prior to expander implantation) and postoperatively in the forehead and scalp regions. We analyzed and compared parameters including expansion efficiency, post-expansion flap retraction force, postoperative pain scores, and complication rates between the two groups.

[RESULTS] Baseline characteristics showed no significant differences between the two groups before expander implantation. During the tissue expansion phase, the experimental group demonstrated significantly higher expansion efficiency compared to the control group. At both 3 and 6 months following flap transfer surgery, the post-expansion flap retraction force was significantly lower in the experimental group than in the control group. However, no significant differences were observed in pain scores or complication rates between the two groups.

[CONCLUSION] Our prospective, comparative study demonstrates that Botulinum toxin application enhances the efficiency of tissue expansion using the fronto-scalp flap for reconstructing large secondary facial and scalp defects. It also reduces post-expansion flap retraction force, ultimately contributing to favorable functional and aesthetic surgical outcomes.

[TRAIL REGISTRATION] ChiCTR1900027702.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 flap 피판재건술 dict 7
시술 botulinum toxin 보툴리눔독소 주사 dict 4
해부 facial scispacy 1
해부 tissue scispacy 1
해부 upper facial scispacy 1
해부 hair scispacy 1
해부 scalp scispacy 1
합병증 forehead scispacy 1
합병증 scalp scispacy 1
합병증 flaps scispacy 1
합병증 scalp lesions scispacy 1
합병증 Craniofacial scispacy 1
약물 [OBJECTIVE] scispacy 1
약물 [RESULTS] scispacy 1
약물 TRAIL C1143949
TNFSF10 protein, human
scispacy 1
약물 ChiCTR1900027702 scispacy 1
약물 [BACKGROUND] scispacy 1
질환 postoperative pain C0030201
Pain, Postoperative
scispacy 1
질환 pain C0030193
Pain
scispacy 1
기타 patients scispacy 1
기타 expander scispacy 1
기타 forehead scispacy 1
기타 TRAIL scispacy 1

MeSH Terms

Humans; Female; Prospective Studies; Male; Middle Aged; Adult; Tissue Expansion; Surgical Flaps; Scalp; Plastic Surgery Procedures; Treatment Outcome; Postoperative Pain; Forehead; Combined Modality Therapy; Face; Botulinum Toxins, Type A; Laser Therapy

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문